Vivani Medical (VANI)
NASDAQ:VANI
Holding VANI?
Track your performance easily

Vivani Medical (VANI) Income Statement

731 Followers

Vivani Medical Income Statement

Last quarter (Q4 2023), Vivani Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Vivani Medical's net income was $-6.03M. See Vivani Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 0.00$ 0.00$ 3.38M
Cost of Revenue
---$ -130.00K$ -500.00K$ 2.15M
Gross Profit
---$ 130.00K$ 500.00K$ 1.23M
Operating Expense
$ 26.96M$ 26.96M$ 21.24M$ 9.06M$ 13.17M$ 31.82M
Operating Income
$ -26.96M$ -26.96M$ -21.24M$ -8.93M$ -12.67M$ -30.60M
Net Non Operating Interest Income Expense
$ -10.08M$ -10.08M-$ 12.00K$ 16.00K$ 362.00K
Other Income Expense
$ -8.00M$ -8.00M$ -6.88M-$ -2.23M$ -3.36M
Pretax Income
$ -25.65M$ -25.65M$ -13.89M$ -8.92M$ -14.88M$ -33.59M
Tax Provision
--$ -1.07M---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -25.65M$ -25.65M$ -13.89M$ -8.92M$ -14.88M$ -33.59M
Basic EPS
---$ -0.81$ -0.72$ -18.24
Diluted EPS
---$ -0.81$ -0.72$ -18.24
Basic Average Shares
---$ 10.94M$ 20.57M$ 1.84M
Diluted Average Shares
---$ 10.94M$ 20.57M$ 1.84M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
-----$ -15.28
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 26.96M$ 26.96M$ 21.24M$ 8.93M$ 12.67M$ 33.98M
Net Income From Continuing And Discontinued Operation
$ -25.65M$ -25.65M$ -13.89M$ -8.92M$ -14.88M$ -33.59M
Normalized Income
$ -23.11M$ -28.27M-$ -8.92M$ -12.65M$ -30.23M
Interest Expense
------
EBIT
$ -26.96M$ -26.96M$ -21.24M$ -8.93M$ -12.67M$ -30.60M
EBITDA
$ -26.61M$ -26.61M$ -20.86M$ -8.86M$ -12.50M$ -30.20M
Currency in USD

Vivani Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis